Curis, Inc. (CRIS)
NASDAQ: CRIS · Real-Time Price · USD
1.960
+0.070 (3.70%)
At close: May 12, 2025, 4:00 PM
2.040
+0.080 (4.08%)
After-hours: May 12, 2025, 6:44 PM EDT
Curis Market Cap
Curis has a market cap or net worth of $20.51 million as of May 12, 2025. Its market cap has decreased by -76.46% in one year.
Market Cap
20.51M
Enterprise Value
34.58M
1-Year Change
-76.46%
Ranking
Category
Stock Price
$1.96
Market Cap Chart
Since August 1, 2000, Curis's market cap has decreased from $613.20M to $20.51M, a decrease of -96.66%. That is a compound annual growth rate of -12.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 19.80M | -23.55% |
| Dec 31, 2024 | 25.90M | -65.47% |
| Dec 29, 2023 | 75.00M | 41.51% |
| Dec 30, 2022 | 53.00M | -87.85% |
| Dec 31, 2021 | 436.10M | -9.47% |
| Dec 31, 2020 | 481.70M | 754.08% |
| Dec 31, 2019 | 56.40M | 147.37% |
| Dec 31, 2018 | 22.80M | -80.14% |
| Dec 29, 2017 | 114.80M | -73.48% |
| Dec 30, 2016 | 432.90M | 15.87% |
| Dec 31, 2015 | 373.60M | 189.61% |
| Dec 31, 2014 | 129.00M | -46.69% |
| Dec 31, 2013 | 242.00M | -11.78% |
| Dec 31, 2012 | 274.30M | -23.47% |
| Dec 30, 2011 | 358.40M | 139.25% |
| Dec 31, 2010 | 149.80M | -30.74% |
| Dec 31, 2009 | 216.30M | 354.41% |
| Dec 31, 2008 | 47.60M | -23.10% |
| Dec 31, 2007 | 61.90M | -0.16% |
| Dec 29, 2006 | 62.00M | -64.71% |
| Dec 30, 2005 | 175.70M | -28.84% |
| Dec 31, 2004 | 246.90M | 36.11% |
| Dec 31, 2003 | 181.40M | 438.28% |
| Dec 31, 2002 | 33.70M | -81.39% |
| Dec 31, 2001 | 181.10M | -21.84% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.16B |
| Johnson & Johnson | 369.09B |
| UnitedHealth Group | 343.81B |
| AbbVie | 332.23B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.03B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |